Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, Leukaemia
Results
Phase 2
This trial looked at dasatinib for children and young people who were newly diagnosed with acute lymphoblastic leukaemia (ALL).
It was for those whose ALL had the .
The trial was for children and young people up to and including the age of 17.
The trial was open for people to join between 2012 and 2014. The team presented results at a conference in 2017 and published results in 2023.
Recruitment start: 4 December 2012
Recruitment end: 29 May 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Vaskar Saha
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Last reviewed: 20 Aug 2024
CRUK internal database number: 9236
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
